Positive Clinical Results for Alzheimer’s Amyloid-Clearing Drug – Lecanemab Poised for FDA Approval

 

Positive results from new amyloid-clearing drug represent a starting point for Alzheimer’s treatment, while combination therapy remains the holy grail. Amyloid-clearing drug lecanemab will be…

 

Positive results from new amyloid-clearing drug represent a starting point for Alzheimer’s treatment, while combination therapy remains the holy grail. Amyloid-clearing drug lecanemab will be…  Health News – SciTechDaily 

Comments

Popular posts from this blog

Google Messages starts testing end-to-end encryption for RCS group texts

‘Diablo IV’ arrives June 6th, 2023

Formula 1 Turns a Decade in Austin Into a Victory Lap Around North America